NCT04438382 2026-02-27
Infliximab and Intravenous Immunoglobulin Therapy in Treating Patients With Steroid-Refractory Pneumonitis
Eastern Cooperative Oncology Group
Phase 2 Terminated
Clinical Trials
4 trialsNCT04728425 2025-04-27
MG_SCIG
University Health Network, Toronto
Phase 2 Completed
NCT01545518 2014-09-01
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
Emory University
Phase 2 Terminated
NCT00294476 2006-10-12
IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma
GammaCan
Phase 2 Unknown